4//SEC Filing
Davis Thomas Andrew 4
Accession 0001179110-12-013996
CIK 0000744218other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 3:06 PM ET
Size
5.4 KB
Accession
0001179110-12-013996
Insider Transaction Report
Form 4
Davis Thomas Andrew
Sr. VP & CMO
Transactions
- Award
Incentive Stock Option
2012-09-12+115,000→ 115,000 totalExercise: $5.69From: 2013-09-12Exp: 2022-09-12→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]25% vest on September 12, 2013 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001338185
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 3:06 PM ET
- Size
- 5.4 KB